June 27, 2019

Biosimilars – 2019 Mid-Year Update

In this webinar, life sciences attorneys John Adkisson, Tasha Francis, and Jenny Shmuel provide a mid-year review on the current status of the U.S. biosimilars space. Topics discussed include:

  • The U.S. biosimilars market: approvals, launches, and anticipated launches
  • FDA guidance
  • Select court cases and appellate guidance
  • Trends in IPRs in the biosimilars space
  • What’s on the horizon for biosimilars
Our hosts also review recent legislative proposals with potential impact on the biosimilars market.
No Comments

Sorry, the comment form is closed at this time.